Views & Analysis Digital health round-up: Apple's 'one-stop shop' Can Apple succeed where others can't?
Views & Analysis Verily, Novartis join fund to support Europe’s biotech entre... New $300m fund aimed at helping European biotechs to grow, providing alternative to an IPO or 'generally suboptimal' licensing or big pharma acquisition
Views & Analysis Digital health round-up: Apple ventures into the Land of Nod Apple becomes first 'big tech' firm to investigate sleep technology.
News Verily launches ambitious Project Baseline Study will create a comprehensive database reference for researchers.
News Verily unveils the Study Watch, a clinical trials-only weara... Device will be used in several upcoming clinical studies.
Views & Analysis Why Novartis and Verily should abandon their smart lens idea Technical officer hinted that the firm has hit obstacles to its ambitious projects.
News TransThera's resistant biliary cancer drug cleared in China TransThera's Yochanra has been cleared in China as the world's first drug that can overcome resistance to FGFR inhibitors in cholangiocarcinoma.
Digital Sponsored Discover a new era of healthcare panel engagement: Grounded ... A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.
